Vol 8, No 3 (2016)
Mol Cell Pharmacol
Table of Contents
Literature Highlights
| Pembrolizumab as First-line Therapy for PD-L1-expressing Lung Cancer | Abstract PDF |
| M. Saeed Sheikh | 13 |
FDA Corner
| FDA approves first drug for spinal muscular atrophy | Abstract PDF |
| 15 |
| FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes | Abstract PDF |
| 16 |
| FDA grants accelerated approval to first drug for Duchenne muscular dystrophy | Abstract PDF |
| 16-17 |
Our partner: Crossroads Pharmacy 2800 Hwy 101, Rogersville, AL 35652 LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 Copyright © 2008 LumiText Publishing. All rights reserved.